EnhancedBio
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $15M
Investors
- 23
About EnhancedBio
Based in Seoul, South Korea, and founded in 2016, EnhancedBio Inc. operates as a biopharmaceutical company that is developing therapies and drugs with the goal of providing cures for cancer disease patients. The company’s anti-cancer therapeutics product pipeline that is at its clinical stage of the trial includes borestrant, ER-PROTAC, BTK-PROTAC, cavisiran (+EN LNP), mevasiran (+EN LNP), and corpitenib, as well as technology EN LNP (Lipid Nano Particle) including LNP for mRNA-based vaccine, siRNA therapeutics, therapeutic protein replacement, genome editing and cell engineering.
Who invested in EnhancedBio
23 investors across 3 rounds
See all investors in EnhancedBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EnhancedBio
Who invested in EnhancedBio?
EnhancedBio has 23 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnhancedBio raised?
EnhancedBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EnhancedBio last raise money?
EnhancedBio's most recent round on record is a Series C, in Dec 2021.
What does EnhancedBio do?
Based in Seoul, South Korea, and founded in 2016, EnhancedBio Inc.
Where is EnhancedBio headquartered?
EnhancedBio is headquartered in Seoul, South Korea.
Which VCs invest in companies like EnhancedBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at EnhancedBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like EnhancedBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.